SERZONE Trademark

Trademark Overview

On Monday, March 20, 2017, a trademark application was filed for SERZONE with the United States Patent and Trademark Office. The USPTO has given the SERZONE trademark a serial number of 87378103. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 5, 2020. This trademark is owned by Gemini Laboratories, LLC. The SERZONE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-depressants
serzone

General Information

Serial Number87378103
Word MarkSERZONE
Filing DateMonday, March 20, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 5, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 4, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-depressants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGemini Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameGemini Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Monday, October 5, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 5, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2020EXTENSION 5 GRANTED
Wednesday, January 22, 2020EXTENSION 5 FILED
Monday, January 27, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 22, 2020TEAS EXTENSION RECEIVED
Friday, August 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2019EXTENSION 4 GRANTED
Wednesday, August 21, 2019EXTENSION 4 FILED
Wednesday, August 21, 2019TEAS EXTENSION RECEIVED
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2019EXTENSION 3 GRANTED
Friday, February 15, 2019EXTENSION 3 FILED
Friday, February 15, 2019TEAS EXTENSION RECEIVED
Wednesday, August 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 13, 2018EXTENSION 2 GRANTED
Monday, August 13, 2018EXTENSION 2 FILED
Monday, August 13, 2018TEAS EXTENSION RECEIVED
Saturday, February 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 15, 2018EXTENSION 1 GRANTED
Thursday, February 15, 2018EXTENSION 1 FILED
Thursday, February 15, 2018TEAS EXTENSION RECEIVED
Tuesday, August 29, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 14, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 23, 2017ASSIGNED TO LIE
Wednesday, April 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, April 19, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 19, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, April 19, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, April 17, 2017ASSIGNED TO EXAMINER
Friday, March 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 23, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

serzone depressants anti namely preparations pharmaceutical